Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ArQule and Acadia forge drug discovery collaboration

April 24, 1998

Targeted Genetics patents retroviral gene delivery system using chimeric proteins

April 24, 1998

GeneMedicine reports advances in muscle gene delivery systems

April 24, 1998

Alza licenses two drug delivery technologies to Alkermes

April 22, 1998

Sheffield signs option agreement with Zambon for MSI delivery system

April 21, 1998

Inhale licenses technology from Initiatech

April 17, 1998

FDA issues approvable letter for expanded use of Ceprate SC System

April 17, 1998

AvMax's essential oils improve oral bioavailability of therapeutic agents

April 16, 1998

Bristol-Myers Squibb and Acacia Biosciences sign drug discovery agreement

April 15, 1998

Rhone-Poulenc Rorer awards seven research grants to Stanford University investigators

April 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...